The ID Pipeline: Drug Development Debrief | Week of September 13, 2020
A quick debrief of the week’s top FDA approvals, FDA authorizations, or other infectious disease pipeline developments from the past week.
FDA Provides Extended List of Hand Sanitizer Recalls
Each week, the FDA posts relevant recalls and other patient safety information. We highlight some of these notices that may be clinically relevant.
Recalls Radar: "Always Be Clean" Hand Sanitizer & More
Weekly, we identify which FDA recall announcements might be most clinically relevant.
FDA Pipeline: EUA Granted for Plasma, Remdesivir Expands to Moderate Cases
A refresher on the week's developments in the infectious disease drug & medical device FDA approval pipeline.
The ID Pipeline: Plasma Authorization Paused, COVID-19 Saliva Test Gets EUA
FDA Salmonella Recall Investigation: Aldi Peaches
FDA is working with local partners to continue the outbreak investigation.
Key FDA Diagnostic Authorizations of the Week
Since the emergence of the SARS-CoV-2 pandemic in particular, news in the infectious disease drug and medical device pipeline has moved at an accelerated pace.
FDA Adds More Toxic Sanitizer to Recall List
Broncolin S.A. de C.V is voluntarily recalling all lots of Herbacil Antiseptic Hand Sanitizer 70% Alcohol to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol).
ID Pipeline News: HHS Purchases Vaccine, FDA Approves Pooled COVID-19 Testing
A round up of the week's infectious disease pipeline developments.
FDA Issues More Sanitizer Recalls Over Methanol Content
Weekly, we identify FDA announcements that pertain to infectious disease care. This week, FDA continued an investigation of undeclared wood alcohol contents in hand sanitizer.
COVID-19 Pandemic Threatens Global Infectious Disease Control Progress
A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
How Will Coronavirus Impact HIV, TB, & Malaria in Developing African Countries?
A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.
Can Baloxavir Limit Spread of Flu Cases Within Families?
New study findings shed light on the positive effects of baloxavir for preventing influenza spread in household settings.
Why is Ebola Endemic to the DRC?
In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.
Complicating the Coronavirus Lockdown Debate
A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.
HIV Screening: Are Primary Care Physicians Following CDC Guidelines?
Dr. Marc Pitasi, epidemiologist, discusses facilitators of routine HIV screening among primary care physicians.
Ebola and Coronavirus Pipeline Developments of the Week
Catch up with a review of our top drug pipeline stories from the past week.
Open Questions in Coronavirus Immunology
Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.
Contagion Live News Network: Coronavirus Mutation Fears Appear Premature
A brief overview of our top stories.
Why Employers Need Infectious Disease Consultation During COVID-19
Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.
Coronavirus Experts Put Mutation Fears in Context
Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?
How People With HIV Respond to COVID-19
Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.
Contagion Live News Network: New COVID 19 Trial for Opaganib
A brief overview of our recent coverage.
Contagion Live News Network: Infectious Disease Updates for June 26, 2020
A brief summary of the latest news.
Clinical Ramifications of Pneumococcal Vaccine Development
Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Contagion Live News Network: Infectious Disease Updates for June 25, 2020
A brief on today's top ID news.
Merck: Advances in the Pneumococcal Conjugate Vaccine Pipeline
In a joint-interview, we discuss the PCV pipeline with Dr. Luwy Musey (of Merck & Co.) and Dr. Steven Pelton.
Contagion Live News Network: Coronavirus Guidelines Discourage Hydroxychloroquine Outside Trials
Video briefing on the day's top infectious disease news.
Applying Cancer Knowledge to COVID Vaccine Research
Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.
Contagion Live News Network: Pneumococcal Conjugate Vaccine V114
An overview of today's top infectious disease stories.
2 Clarke Drive Cranbury, NJ 08512